CBD Life Sciences Inc. (OTCMKTS:CBDL) Short Interest Update

CBD Life Sciences Inc. (OTCMKTS:CBDL) was the recipient of a significant increase in short interest in August. As of August 31st, there was short interest totaling 27,672 shares, an increase of ∞ from the August 15th total of 0 shares. Based on an average trading volume of 3,765,865 shares, the days-to-cover ratio is currently 0.0 days.

CBD Life Sciences Price Performance

CBDL opened at $0.00 on Wednesday. CBD Life Sciences has a 1-year low of $0.00 and a 1-year high of $0.00.

CBD Life Sciences Company Profile

CBD Life Sciences, Inc is a U.S.-based company focused on developing and commercializing cannabinoid‐enhanced products for the wellness and consumer healthcare markets. The company’s core strategy centers on leveraging plant-derived phytocannabinoids, along with complementary natural ingredients, to formulate a range of topical and ingestible offerings. CBD Life Sciences operates under an emerging‐brand model, seeking to position its products at the intersection of pharmaceutical‐grade quality and mainstream consumer appeal.

The company’s product portfolio includes broad‐spectrum hemp-derived topical creams, gels and balms designed for localized relief, as well as oral formulations such as capsules, tinctures and soft gels aimed at general wellness support.